TickerFacts.

BridgeBio Oncology Therapeutics, Inc. (BBOT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

31.14M
Year ended 2025-12-31
2024-12-31: 12.9K2025-12-31: 31.14M31.14M
2024-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3131.14Mn/m2026-03-05, From 2025-01-01
2024-12-3112.9Kn/a2026-03-05, From 2024-01-01